Drug Information

Drug General Information
Drug ID
D0F470
Drug Name
FP-025
Indication Asthma [ICD9: 493; ICD10:J45] Phase 1 [1725890]
Target and Pathway
Target(s) MMP-12 Target Info Inhibitor [1725885]
NetPath Pathway IL1 Signaling Pathway
IL5 Signaling Pathway
Pathway Interaction Database Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
Reactome Collagen degradation
Degradation of the extracellular matrix
WikiPathways TGF beta Signaling Pathway
Degradation of collagen
Matrix Metalloproteinases
References
Ref 1725890ClinicalTrials.gov (NCT02238834) Phase 1 Safety, Tolerability and Pharmacokinetics (PK) Study of FP-025 in Healthy Volunteers
Ref 1725885Potential clinical implications of recent matrix metalloproteinase inhibitor design strategies.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.